×

The RACGP is undergoing scheduled system maintenance: Wednesday, 17 April 2024 from 8:15PM – 10:15 PM AEST. During the maintenance window, some RACGP services will experience disruptions.
We apologise for any inconvenience caused.


RACGP submission to the Nursing and Midwifery Board of Australia on the Consultation regulation impact statement: Registration standard: Endorsement for scheduled medicines – designated registered nurse prescriber


Last updated 10 August 2023

Date: 7 August 2023

The RACGP has provided a submission to the Nursing and Midwifery Board of Australia on the Consultation regulation impact statement: Registration standard: Endorsement for scheduled medicines – designated registered nurse prescriber.
 
The RACGP supports Option 1 – ‘Retain the status quo prescribing practice.’ However, RACGP could potentially consider Option 2a in areas of identified need and subject to more detail on specific models and the conditions being treated.  The RACGP does not support registered nurse prescribing of schedule 8 medicines.

Read the submission

RACGP submission to the Nursing and Midwifery Board of Australia on the Consultation regulation impact statement: Registration standard: Endorsement for scheduled medicines – designated registered nurse prescriber (PDF)

Advertising

Advertising